Genmab News

Oct 21, 2020 at 10:48 PM CEST Genmab Announces IFM, HOVON and Janssen Achieve Positive Topline Results in Second Part of Phase 3 CASSIOPEIA Study of Daratumumab in Multiple Myeloma at Pre-planned Interim Analysis	Download
Oct 15, 2020 at 3:35 PM CEST Genmab A/S has published its Articles of Association	Download
Oct 15, 2020 at 3:03 PM CEST Genmab to Host Capital Markets Day	Download
Oct 14, 2020 at 11:15 PM CEST Genmab Announces Data to be Presented at SITC 35th Anniversary Annual Meeting	Download
Oct 13, 2020 at 12:42 PM CEST Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2020	Download
Oct 7, 2020 at 11:13 PM CEST Grant of Restricted Stock Units and Warrants to Employees in Genmab	Download
Sep 30, 2020 at 6:56 PM CEST Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons	Download
Sep 30, 2020 at 4:09 PM CEST Genmab A/S has published its Articles of Association	Download
Sep 29, 2020 at 9:48 PM CEST Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons	Download
Sep 29, 2020 at 9:37 PM CEST Capital Increase in Genmab as a Result of Employee Warrant Exercise	Download
Sep 22, 2020 at 11:04 PM CEST Genmab Commences Binding Arbitration of Two Matters Under License Agreement with Janssen	Download
Sep 21, 2020 at 4:20 PM CEST Genmab and Seattle Genetics Present Data from Tisotumab Vedotin innovaTV 204 Pivotal Trial in Recurrent or Metastatic Cervical Cancer at ESMO Virtual Congress 2020	Download
Sep 10, 2020 at 2:07 PM CEST Genmab Announces that Janssen has Submitted a Supplemental Biologics License Application to U.S. FDA for use of DARZALEX FASPRO™ (daratumumab and hyaluronidase-fihj) in Patients with Light-chain (AL) Amyloidosis	Download
Sep 9, 2020 at 2:48 PM CEST Genmab to Present at Morgan Stanley 18th Annual Global Healthcare Conference	Download
Aug 27, 2020 at 12:05 AM CEST Genmab Announces Late-Breaking Oral Presentation of Phase 2 innovaTV 204 Study at the ESMO Virtual Congress 2020	Download
Aug 20, 2020 at 10:40 PM CEST Genmab Announces Janssen Granted U.S. FDA Approval for DARZALEX® (daratumumab) in Combination with Carfilzomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma	Download
Aug 20, 2020 at 10:06 PM CEST Genmab Announces Plan to Transition Arzerra® (ofatumumab) to an Oncology Access Program for Chronic Lymphocytic Leukemia Patients in the U.S.	Download
Aug 20, 2020 at 7:33 PM CEST U.S. FDA Approves Kesimpta® (ofatumumab) in Relapsing Multiple Sclerosis	Download
Aug 19, 2020 at 2:55 PM CEST Genmab A/S has published its Articles of Association	Download
Aug 18, 2020 at 9:40 PM CEST Capital Increase in Genmab as a Result of Employee Warrant Exercise	Download
Aug 12, 2020 at 5:23 PM CEST Genmab Announces Financial Results for the First Half of 2020	Download
Jul 31, 2020 at 9:37 PM CEST Genmab Announces European Myeloma Network and Janssen Achieve Positive Topline Results from Phase 3 APOLLO Study of Daratumumab in Combination with Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma	Download
Jul 20, 2020 at 5:57 PM CEST Major Shareholder Announcement	Download
Jul 16, 2020 at 12:43 PM CEST Genmab Announces Net Sales of DARZALEX® for the Second Quarter of 2020	Download
Jul 7, 2020 at 1:01 PM CEST Major Shareholder Announcement	Download

NEWS & EVENTS

Through timely company announcements, media releases, events and presentations, Genmab discloses and informs all our stakeholders of key events throughout the year.

Genmab News

Genmab News

Who we are

Turning insights into medicine

Innovation for the future

Genmab A/S

Genmab B.V.

Genmab US, Inc.

Genmab K.K.

You are now leaving Genmab.com to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.